Krause Kevin Michael

Track

Insider profile

Krause Kevin Michael's trades of AN2 Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
242.03
Quantity 19,516 +7.0%
Value US$4,115,622
Transaction date
Planned sale
Price
336.26
Quantity 76,617 -17.6%
Value US$663,578
Transaction date
Proposed sale
Price
169.76
Quantity 65,445
Value US$465,972
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-01-11 2024-01-09
PlS Planned sale
19,516 +7.0%
242.03
US$4,115,622 		19,516 +7.0% 242.03 US$4,115,622
2024-01-04 2024-01-02
PlS Planned sale
76,617 -17.6%
336.26
US$663,578 		76,617 -17.6% 336.26 US$663,578
2024-01-02 2024-01-02
PrS Proposed sale
65,445
169.76
US$465,972 		65,445 169.76 US$465,972